Clinical trial
A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic…
NCT00375960 · Vernalis (R&D) Ltd, Industry · Completed
Key facts
| NCT number | NCT00375960 |
|---|---|
| Title | A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Crossover Study of the Safety, Efficacy and Pharmacokinetics of Two Escalating, Oral Doses of V3381 (200 mg BID and 400 mg BID) for 28 Days in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) |
| Lead sponsor | Vernalis (R&D) Ltd, Industry |
| Collaborators | Cita NeuroPharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain, Diabetic Neuropathies |
| Intervention type | Drug |
| Interventions | V3381, Placebo |
| Enrollment | 50 |
| Start date | Jun 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Sep 13, 2006 |
| Last update posted | Apr 2, 2007 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: